IV - Articles and news items

FDA grants QIDP for C. Difficile IV treatment

Industry news / 25 July 2016 / Niamh Louise Marriott, Digital Content Producer

Morphochem announced today that the U.S. FDA has designated Morphochem’s intravenous antibacterial product as a Qualified Infectious Disease Product…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+